세계 투시 검사 장치 시장 - 인사이트, 경쟁 구도, 시장 예측(2030년)

Fluoroscopy Equipment By Product Type (Fixed C-Arm Systems And Mobile C-Arm Systems), Application (Cardiology, Respiratory, Oncology, And Others), End-User (Hospitals And Clinics, Diagnostic Centers, And Others), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of chronic diseases globally, increase in product launches, and increasing awareness about early disease detection

The fluoroscopy equipment device market was valued at USD 5.30 billion in 2023, growing at a CAGR of 4.74% during the forecast period from 2024 to 2030 to reach USD 7.30 billion by 2030. The demand for fluoroscopy equipment is primarily being boosted by the rising prevalence of chronic diseases such as Coronary Artery Disease (CAD), Chronic Obstructive Pulmonary Disease (COPD), among others globally, increase in product launches, and rising awareness about early disease detection are some factors contributing to the positive growth of the fluoroscopy equipment market during the forecast period from 2024 to 2030.

Fluoroscopy Equipment Dynamics:

As per the recent data provided by the World Heart Report (2023), in 2021 it was stated that more than half a billion people were living with cardiovascular diseases globally.

According to British Heart Foundation, Global Heart & Circulatory Diseases Factsheet (2024), it stated that around 200 million people were living with CAD around the world. Therefore, with rise in the cases of cardiovascular disorders, there's a growing demand for advanced diagnostic options like fluoroscopy equipment. These play a crucial role in the diagnosis and treatment of various cardiovascular conditions.

According to the data provided by WHO (2024), in 2019 that there were 262 million people affected by asthma. Additionally in 2023, there were 392 million people living with COPD globally, with three quarters of them living in low and middle income countries. As, respiratory diseases often lead to complications such as asthma and COPD, it spurs the critical need for advanced diagnostic and treatment options. Therefore, the growing incidence of respiratory diseases directly contributes to the expanding market for fluoroscopy equipment.

Moreover, the increased number of product launches in the fluoroscopy equipment globally is also expected to boost the overall market growth. For instance, in January 2024, Carestream Health, Inc. launched an X-ray system called DXR-Excel Plus. It is a two-in-one system for both fluoroscopy and general radiology that delivers real-time, images for a wide range of examinations.

Therefore, considering the large patient pool associated with different chronic disorders, and the rising product launches globally, the market for fluoroscopy equipment is expected to grow significantly during the given forecast period from 2024 to 2030.

However, prolonged or repeated exposure to ionizing radiations that raise risks for patients as well as for healthcare professionals, availability of other alternative equipments, among others are some of the key constraints that may limit the growth of the fluoroscopy equipment.

Fluoroscopy Equipment Segment Analysis:

Fluoroscopy Equipment by Product type (Fixed C-Arm Systems and Mobile C-Arm Systems), Application (Cardiology, Respiratory, Oncology, and Others), End-User (Hospitals and Clinics, Diagnostic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest Of The World)

In the product type segment of the fluoroscopy equipment, the mobile C-arm system category was estimated to amass a significant revenue share in the fluoroscopy equipment market in 2023. Portability and flexibility of mobile C-arm systems have become more common, particularly in ambulatory surgical clinics, emergency rooms, and operating rooms. The need for mobile C-arms has been rising gradually in recent years as a result of technological improvements that enabled them to produce high-quality images. Their increasing market share has also been aided by the growing trend towards minimally invasive treatments, which frequently need mobile C-arm imaging guidance.

Additionally, product launches in this category are also expected to drive the market growth for the mobile c-arms category. For example, In July 2022, FUJIFILM Holdings Corporation announced US launch of the FDR Cross, an innovative hybrid c-arm and portable x-ray solution built for hospitals and ambulatory surgery centers (ASC). The dual-function c-arm was the first of its kind to offer portable fluoroscopic and radiographic imaging on a single platform.

Moreover, Mobile C-arm fluoroscope equipment is a highly versatile and essential tool in contemporary medical imaging, particularly in surgery and interventional radiology. They boast advanced imaging capabilities with digital flat-panel detectors that deliver superior image quality with lower radiation doses. They also feature user-friendly touch screens and intuitive interfaces, making them accessible to medical professionals. Some models include 3D imaging and navigation systems, which are crucial for complex procedures.

Therefore, the various advantages and applications provided by the mobile C arm fluoroscopy equipment category will contribute to the growth of the segment, thereby driving the growth of the overall fluoroscopy equipment market during the forecast period.

North America Is Expected To Dominate The Overall Fluoroscopy Equipment:

North America is expected to account for the highest proportion of the fluoroscopy equipment market in 2023, out of all regions due to several key factors. The high incidence of chronic diseases, including cardiovascular conditions and respiratory illnesses, increases the demand for accurate diagnostic and treatment tools. Additionally, the efficient regulatory frameworks that ensure the safety and efficacy of medical devices further encourage the adoption of fluoroscopy equipment in clinical settings, also the increased product launches in the US. Together, these factors drive the expansion of the fluoroscopy equipment market in North America.

According to the latest updated data provided by the Centers for Disease Control and Prevention (CDC) (2024), it was stated that 805,000 people in the US had a heart attack every year, and about 1 out of 5 are silent heart attacks.

Additionally, the latest data provided by the National Institute of Health (2023), stated that 20.5 million people in the US were living with CAD. Fluoroscopy is vital for visualizing the heart and blood vessels in real-time, identifying blockages, abnormalities, and reduced blood flow for early intervention. It guides procedures like angioplasty and stent placement with precision, ensuring optimal outcomes in managing heart conditions. Therefore, the high incidence of heart attacks and the widespread prevalence of coronary artery disease may siginificantly increase the demand for fluoroscopy equipment during the forecast period.

According to the latest updated data by the American Lung Association, in 2023 approximately 11.7 million people in the US were living with chronic respiratory disorders, which over time made it harder for patients to breathe.

Furthermore, as per the data provided by CDC (2023), in 2021, approximately 14.2 million people in the US had chronic obstructive pulmonary disease (COPD). Fluoroscopy's real-time imaging helps identify respiratory system issues like blockages. During procedures like bronchoscopy, it guides physicians to navigate airways precisely, visualize problem areas, and collect diagnostic samples.

Thus the increase in various respiratory disorders requires precise diagnosis and treatment, the importance of fluoroscopy equipment in respiratory care is increasingly recognized, thus driving the demand for fluoroscopy equipment.

Furthermore, increased product launches in North America also plays a major role in the increasing market for fluoroscopy equipment. For instance, in June 2021, FUJIFILM Holdings Corporation, Inc., announced the launch of Persona RF PREMIUM's in the US market. The Persona RF PREMIUM is a unique radiography and fluoroscopy system that offered real-time imaging for the skeletal, digestive, urinary, respiratory, and reproductive systems, as well as for particular organs like the kidneys, heart, and lung.

Thus, due to the interplay of all the above-mentioned factors, it will lead to an increase in the North American fluoroscopy equipment market growth during the forecast period from 2024 to 2030.

Fluoroscopy Equipment Key Players:

Some of the key market players operating in the fluoroscopy equipment include Siemens Healthcare Private Limited, GE HealthCare, Koninklijke Philips N.V, Shimadzu Corporation, Ziehm Imaging GmbH, Carestream Health, Inc., Orthoscan, Inc., CANON MEDICAL SYSTEMS CORPORATION, FUJIFILM Holdings Corporation, Allengers, DMS Group, Villa Sistemi Medicali Spa, Eurocolumbus srl, Genoray Co., Ltd., Bimedis, Omega Medical Imaging, LLC., Hologic, Inc, Adani Systems Inc, Agfa-Gevaert Group, Scanray Technologies Limited, and others.

Recent Developmental Activities In The Fluoroscopy Equipment:

• In November 2023, The Norwegian Vestre Viken Health Trust and Philips announced that AI-enabled clinical care had been implemented to help radiologists improve patient care. The clinical applications platform powered by AI from Philips will expedite the diagnosis of bone fractures.
• In September 2021, Siemens Healthcare Private Limited launched Luminos Impulse that offered high efficiency for digital fluoroscopy and radiography. It included seamless imaging chain, comprehensive dose optimization, cybersecurity features, and detector-sharing capabilities for radiography.

Key Takeaways From The Fluoroscopy Equipment Report Study

• Market size analysis for current fluoroscopy equipment size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global fluoroscopy equipment.
• Various opportunities available for the other competitors in the fluoroscopy equipment space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current fluoroscopy equipment scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for fluoroscopy equipment growth in the coming future?

Target Audience Who Can Be Benefited From The Fluoroscopy Equipment Report Study

• Fluoroscopy equipment product providers
• Research organizations and consulting companies
• Fluoroscopy equipment-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in fluoroscopy equipment
• Various end-users who want to know more about the fluoroscopy equipment and the latest technological developments in the fluoroscopy equipment

Frequently Asked Questions For The Fluoroscopy Equipment:

1. What are fluoroscopy equipment?

Fluoroscopy equipment is a medical imaging technology that uses X-rays to produce moving, real-time images of a patient's interior tissues. It is made up of an X-ray source, a display monitor, a collimator, and a fluorescent screen or image intensifier.

2. What is the market for fluoroscopy equipment?

The fluoroscopy equipment device market was valued at USD 5.30 billion in 2023, growing at a CAGR of 4.74% during the forecast period from 2024 to 2030 to reach USD 7.30 billion by 2030.

3. What are the drivers for the fluoroscopy equipment?

The fluoroscopy equipment is slated to witness prosperity owing to factors such as the rising prevalence of chronic diseases such as Coronary Artery Disease (CAD) and Chronic Obstructive Pulmonary Disease (COPD) globally, an increase in product launches, and the rising awareness about early disease detection, among others thus contributing to the positive growth of the fluoroscopy equipment market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the fluoroscopy equipment?

Some of the key market players operating in the fluoroscopy equipment include Siemens Healthcare Private Limited, GE HealthCare, Koninklijke Philips N.V, Shimadzu Corporation, Ziehm Imaging GmbH, Carestream Health, Inc., Orthoscan, Inc., CANON MEDICAL SYSTEMS CORPORATION, FUJIFILM Holdings Corporation, Allengers, DMS Group, Villa Sistemi Medicali Spa, Eurocolumbus srl, Genoray Co., Ltd., Bimedis, Omega Medical Imaging, LLC., Hologic, Inc, Adani Systems Inc, Agfa-Gevaert Group, Scanray Technologies Limited, and others.

5. Which region has the highest share in the fluoroscopy equipment?

North America is expected to dominate the overall Fluoroscopy Equipment during the forecast period from 2024 to 2030. This is owing to the high incidence of chronic diseases, including cardiovascular conditions and respiratory illnesses, increasing the demand for accurate diagnostic and treatment tools. Additionally, the efficient regulatory frameworks that ensure the safety and efficacy of medical devices, and the increased product launches further encourage the adoption of fluoroscopy equipment in clinical settings in the US. Together, these factors are expected to drive the expansion of the fluoroscopy equipment market in North America.

Table of Contents

1. Fluoroscopy Equipment Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Fluoroscopy Equipment Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Fluoroscopy Equipment Market Key Factors Analysis

• 5.1. Fluoroscopy Equipment Market Drivers
  • 5.1.1. The rising prevalence of chronic diseases globally
  • 5.1.2. Increase in product launches
  • 5.1.3. Increasing awareness about early disease detection
• 5.2. Fluoroscopy Equipment Market Restraints and Challenges
  • 5.2.1. Prolonged or repeated exposure to ionizing radiation that raises risks for patients and healthcare professionals
• 5.3. Fluoroscopy Equipment Market Opportunities
  • 5.3.1. Integration with AI to facilitate procedure optimization

6. Fluoroscopy Equipment Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Fluoroscopy Equipment Market Assessment

• 7.1. By Product Type
  • 7.1.1. Fixed C-Arm Systems
  • 7.1.2. Mobile C-Arm Systems
• 7.2. By Application
  • 7.2.1. Cardiology
  • 7.2.2. Respiratory
  • 7.2.3. Oncology
  • 7.2.4. Others
• 7.3. By End-User
  • 7.3.1. Hospitals and Clinics
  • 7.3.2. Diagnostic Centers
  • 7.3.3. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States Fluoroscopy Equipment Size in USD million (2021-2030)
    • 7.4.1.2. Canada Fluoroscopy Equipment Size in USD million (2021-2030)
    • 7.4.1.3. Mexico Fluoroscopy Equipment Size in USD million (2021-2030)
  • 7.4.2. Europe
    • 7.4.2.1. France Fluoroscopy Equipment Size in USD million (2021-2030)
    • 7.4.2.2. Germany Fluoroscopy Equipment Size in USD million (2021-2030)
    • 7.4.2.3. United Kingdom Fluoroscopy Equipment Size in USD million (2021-2030)
    • 7.4.2.4. Italy Fluoroscopy Equipment Size in USD million (2021-2030)
    • 7.4.2.5. Spain Fluoroscopy Equipment Size in USD million (2021-2030)
    • 7.4.2.6. Rest of Europe Fluoroscopy Equipment Size in USD million (2021-2030)
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China Fluoroscopy Equipment Size in USD million (2021-2030)
    • 7.4.3.2. Japan Fluoroscopy Equipment Size in USD million (2021-2030)
    • 7.4.3.3. India Fluoroscopy Equipment Size in USD million (2021-2030)
    • 7.4.3.4. Australia Fluoroscopy Equipment Size in USD million (2021-2030)
    • 7.4.3.5. South Korea Fluoroscopy Equipment Size in USD million (2021-2030)
    • 7.4.3.6. Rest of Asia-Pacific Fluoroscopy Equipment Size in USD million (2021-2030)
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. Middle East Fluoroscopy Equipment Size in USD million (2021-2030)
    • 7.4.4.2. Africa Fluoroscopy Equipment Size in USD million (2021-2030)
    • 7.4.4.3. South America Fluoroscopy Equipment Size in USD million (2021-2030)

8. Fluoroscopy Equipment Market Company and Product Profiles

• 8.1. Siemens Healthcare Private Limited
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. GE HealthCare
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Koninklijke Philips N.V
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Shimadzu Corporation
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Ziehm Imaging GmbH
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Carestream Health, Inc.
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Orthoscan, Inc.
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. CANON MEDICAL SYSTEMS CORPORATION
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. FUJIFILM Holdings Corporation
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Allengers
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. DMS Group
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Villa Sistemi Medicali Spa
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Eurocolumbus srl
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. Genoray Co., Ltd.
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Bimedis
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. Omega Medical Imaging, LLC
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. Hologic, Inc
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. Adani Systems Inc.
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. Agfa-Gevaert Group
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. Scanray Technologies Limited
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us